Table 1.
Experimental Groups
| Group | Cell type | Number | Bolus | Modifications | n |
|---|---|---|---|---|---|
| A | MSC | 2 × 106 | One | None | 5 |
| B | MSC | 4 × 106 | Two | None | 5 |
| C | MSC | 2 × 106 | One | Passage one | 4 |
| D | MSC | 2 × 106 | One | P188 treatment | 5 |
| E | MSC | 2 × 106 | One | P-selectin antibody | 5 |
| F | MSC | 2 × 106 | One | VCAM-1 antibody | 5 |
| G | MSC | 2 × 106 | One | CD49d | 2 |
| H | MAPC | 2 × 106 | One | None | 5 |
| I | BMMC | 2 × 106 | One | None | 5 |
| J | NSC | 2 × 106 | One | None | 5 |
Abbreviations: MSC, mesenchymal stem cells; MAPC, multipotent adult progenitor cells; BMMC, bone marrow-derived mononuclear cells; NSC, neural stem cells; P188, polyoxamer 188; P-selectin, animal pretreatment with anti-P-selectin antibody; VCAM-1, animal pretreatment with anti-VCAM-1 antibody; CD49d, MSC pretreatment with anti-CD49d antibody.